Dao-Quan Peng
Overview
Explore the profile of Dao-Quan Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Dou K, Zhou Z, Zhao D, Ye P, Chen H, et al.
Clin Pharmacol Ther
. 2024 Mar;
115(5):954-964.
PMID: 38459425
The clinical benefits of statins have well-established and recognized worldwide. Although statins are well-tolerated generally, however, the report of statin-related adverse event and statin intolerance are common in China, which...
2.
Li J, Zhao S, Zhao D, Lu G, Peng D, Liu J, et al.
J Geriatr Cardiol
. 2023 Oct;
20(9):621-663.
PMID: 37840633
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for ASCVD. Considering...
3.
Li J, Zhao S, Zhao D, Lu G, Peng D, Liu J, et al.
Front Pharmacol
. 2023 Sep;
14:1190934.
PMID: 37711173
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for ASCVD. Considering...
4.
Su X, Kong Y, Peng D
Lipids Health Dis
. 2018 Jul;
17(1):174.
PMID: 30053818
Apolipoprotein A5 (apoA5) has been identified to play an important role in lipid metabolism, specifically in triglyceride (TG) and TG-rich lipoproteins (TRLs) metabolism. Numerous evidence has demonstrated for an association...
5.
Su X, Peng D
Lipids Health Dis
. 2018 Jan;
17(1):12.
PMID: 29334984
Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor...
6.
Deng T, Ou B, Peng D
J Geriatr Cardiol
. 2018 Jan;
14(11):712-714.
PMID: 29321803
No abstract available.
7.
Luo F, Guo Y, Ruan G, Long J, Zheng X, Xia Q, et al.
Sci Rep
. 2017 May;
7(1):2169.
PMID: 28526884
Statins are widely used to reduce cardiovascular risk. Unfortunately, some patients still experience cardiovascular events though prescribed with high-intensity statins. Metformin, an anti-diabetic drug, was reported to possess anti-atherosclerotic effects....
8.
Hu D, Yang Y, Peng D
Int J Cardiol
. 2016 Nov;
227:61-65.
PMID: 27846466
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown to play a crucial role in the metabolism of low density lipoprotein receptor (LDLR). Sortilin, encoded by the dyslipidemia-related gene...
9.
Hu D, Peng D, Li X, Yu B
Medicine (Baltimore)
. 2016 Nov;
95(45):e5313.
PMID: 27828851
Introduction: Localized pericardium restriction is a rare disease and likely to be unrecognized owing to the atypical manifestation, even after diagnostic avenues are exhausted. Recognizing the red flags of the...
10.